| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2007 ( Subtotal = $392,525 ) |
| | 2007 | 2007 | ARGOLYN BIOSCIENCE INC | 2750 SPEISSEGGER DRIVE | NORTH CHARLESTON | SC | 29405 | CHARLESTON | USA | R44MH065099 | Novel Neurotensin Analogs as Antischizophrenics | 000 | 5 | NIH | 6/26/2007 | $392,525 |
|
| Issue Date FY: 2006 ( Subtotal = $640,992 ) |
| | 2006 | 2006 | ARGOLYN BIOSCIENCE INC | 2750 SPEISSEGGER DRIVE | NORTH CHARLESTON | SC | 29405 | CHARLESTON | USA | R43GM079044 | DEVELOPMENT OF NEUROTENSIN-BASED ANALGESICS | 000 | 1 | NIH | 8/8/2006 | $163,945 |
| | 2006 | 2006 | ARGOLYN BIOSCIENCE INC | 2750 SPEISSEGGER DRIVE | NORTH CHARLESTON | SC | 29405 | CHARLESTON | USA | R44MH065099 | Novel Neurotensin Analogs as Antischizophrenics | 000 | 4 | NIH | 6/27/2006 | $477,047 |
|
| Issue Date FY: 2005 ( Subtotal = $475,884 ) |
| | 2005 | 2005 | ARGOLYN BIOSCIENCE INC | 261 CALHOUN STREET | CHARLESTON | SC | 29425 | CHARLESTON | USA | R44MH065099 | Novel Neurotensin Analogs as Antischizophrenics | 000 | 3 | NIH | 6/30/2005 | $475,884 |
|
|
